Financials
Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 253 M236 M249 M259 M265 M213 M 986 M Research & development —————— — Operating income 229 M51 M68 M353 M240 M245 M 906 M Non-Operating Income, Total -68 M4 M-53 M72 M-69 M-49 M -99 M Interest expense, net of interest capitalized 27 M26 M26 M27 M26 M25 M 104 M Non-Operating Income, excl. Interest Expenses -95 M-22 M-79 M45 M-95 M-74 M -203 M Unusual income/expense —————— — Pretax income 55 M126 M125 M164 M18 M111 M 418 M Equity in earnings —————— — Taxes 20 M36 M35 M9 M4 M31 M 79 M Non-controlling/minority interest 31 M31 M32 M31 M33 M32 M 128 M After tax other income/expense —————— — Net income before discontinued operations 4 M59 M58 M124 M-19 M48 M 211 M Discontinued operations -5 M-5 M-7 M-8 M21 M-1 M 5 M Net income -1 M54 M51 M116 M2 M47 M 216 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -1 M54 M51 M116 M2 M47 M 216 M Basic earnings per share (Basic EPS) 0.010.130.120.2900.12 0.53 Diluted earnings per share (Diluted EPS) 0.010.130.120.280.010.12 0.53 Average basic shares outstanding 433.9 M418.3 M413.2 M408 M409 M388.1 M — Diluted shares outstanding 439.4 M422.9 M417.5 M413.3 M414 M393.7 M — EBITDA 201 M202 M221 M317 M207 M214 M 959 M EBIT 229 M234 M258 M353 M240 M245 M 1.1 B Cost of revenue 1.3 B1.32 B1.29 B1.32 B1.28 B1.32 B 5.21 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) -28 M-32 M-37 M-36 M-33 M-31 M -137 M